115 related articles for article (PubMed ID: 1932621)
1. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.
Beuth J; Ko HL; Gabius HJ; Pulverer G
In Vivo; 1991; 5(1):29-32. PubMed ID: 1932621
[TBL] [Abstract][Full Text] [Related]
2. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
Braun JM; Ko HL; Schierholz JM; Beuth J
Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of immune responses to neem leaf extract (Azadirachta indica) correlates with antineoplastic activity in BALB/c-mice.
Beuth J; Schneider H; Ko HL
In Vivo; 2006; 20(2):247-51. PubMed ID: 16634526
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
Schaffrath B; Mengs U; Schwarz T; Hilgers RD; Beuth J; Möckel B; Lentzen H; Gerstmayer B
Anticancer Res; 2001; 21(6A):3981-7. PubMed ID: 11911280
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract.
Beuth J; Stoffel B; Ko HL; Jeljaszewicz J; Pulverer G
Arzneimittelforschung; 1995 Nov; 45(11):1240-2. PubMed ID: 8929248
[TBL] [Abstract][Full Text] [Related]
6. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
In Vivo; 1994; 8(6):989-92. PubMed ID: 7772751
[TBL] [Abstract][Full Text] [Related]
7. [Immunoactive action of mistletoe lectin-1 in relation to dose].
Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
Arzneimittelforschung; 1994 Nov; 44(11):1255-8. PubMed ID: 7848341
[TBL] [Abstract][Full Text] [Related]
8. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
Beuth J; Ko HL; Tunggal L; Steuer MK; Geisel J; Jeljaszewicz J; Pulverer G
In Vivo; 1993; 7(5):407-10. PubMed ID: 8110981
[TBL] [Abstract][Full Text] [Related]
9. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
Beuth J; Schierholz JM; Ko HL; Braun JM
In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice.
Stoffel B; Krämer K; Mayer H; Beuth J
Anticancer Res; 1997; 17(3C):1893-6. PubMed ID: 9216641
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of immune responses to suramin correlates with antineoplastic activity in BALB/c-mice.
Ko HL; Beuth J; Tunggal L; Gil M; Jeljaszewicz J; Pulverer G
In Vivo; 1994; 8(2):173-6. PubMed ID: 7919119
[TBL] [Abstract][Full Text] [Related]
12. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
[TBL] [Abstract][Full Text] [Related]
13. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory beta-galactoside-specific lectin from mistletoe: partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells.
Gabius HJ; Walzel H; Joshi SS; Kruip J; Kojima S; Gerke V; Kratzin H; Gabius S
Anticancer Res; 1992; 12(3):669-75. PubMed ID: 1622124
[TBL] [Abstract][Full Text] [Related]
15. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
Heiny BM; Beuth J
Anticancer Res; 1994; 14(3B):1339-42. PubMed ID: 8067703
[TBL] [Abstract][Full Text] [Related]
16. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulating and antimetastatic activity of thymic peptides in BALB/c mice.
Beuth J; Schierholz JM; Mayer G
Anticancer Res; 1999; 19(4B):2993-5. PubMed ID: 10652583
[TBL] [Abstract][Full Text] [Related]
18. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R
Nat Immun; 1996-1997; 15(6):295-311. PubMed ID: 9523281
[TBL] [Abstract][Full Text] [Related]
19. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
Gabius S; Gabius HJ
Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
[No Abstract] [Full Text] [Related]
20. Galactoside-specific misletoe lectin modulates dexamethasone-induced apoptosis and glucocorticoid receptor level in Balb/c thymocytes.
Hajtó T; Berki T; Pálinkás L; Boldizsár F; Nagy G; Németh P
In Vivo; 2003; 17(2):163-7. PubMed ID: 12792979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
